Replimune (REPL) Capital Leases (2019 - 2026)
Replimune (REPL) reported Capital Leases of $21.9 million for Q1 2026, down 3.61% on a YoY basis from $22.7 million in Q1 2025, and down 0.99% sequentially from $22.1 million in Q4 2025.
Replimune (REPL) Capital Leases (2019 - 2026) Analysis & Trends
Replimune (REPL) has 8 years of Capital Leases data on file, last reported at $21.9 million in Q1 2026.
- For the quarter ending Q1 2026, Capital Leases fell 3.61% year-over-year to $21.9 million; the trailing twelve-month figure through Mar 2026 stood at $21.9 million (down 3.61% YoY), and the FY2026 full-year result was $21.9 million, down 3.61% from the prior year.
- Capital Leases retreated to $21.9 million in Q1 2026, from $22.1 million in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $24.4 million in Q1 2022 to a low of $21.9 million in Q1 2026.
- A 5-year average of $23.3 million and a median of $23.4 million in 2024 frame the typical range for Capital Leases.
- Across the five-year window, Capital Leases dropped 1.37% in 2022 and retreated 3.61% in 2026, its largest moves.
- Tracing REPL's Capital Leases over 5 years: stood at $24.1 million in 2022, then retreated by 2.18% to $23.6 million in 2023, then slipped by 2.75% to $22.9 million in 2024, then dropped by 3.42% to $22.1 million in 2025, then dropped by 0.99% to $21.9 million in 2026.
- Business Quant data shows REPL's Capital Leases at $21.9 million in Q1 2026, $22.1 million in Q4 2025, and $22.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.91 Mn |
| Dec 31, 2025 | 22.13 Mn |
| Sep 30, 2025 | 22.34 Mn |
| Jun 30, 2025 | 22.54 Mn |
| Mar 31, 2025 | 22.73 Mn |
| Dec 31, 2024 | 22.91 Mn |
| Sep 30, 2024 | 23.09 Mn |
| Jun 30, 2024 | 23.26 Mn |
| Mar 31, 2024 | 23.41 Mn |
| Dec 31, 2023 | 23.56 Mn |
| Sep 30, 2023 | 23.71 Mn |
| Jun 30, 2023 | 23.84 Mn |
| Mar 31, 2023 | 23.97 Mn |
| Dec 31, 2022 | 24.09 Mn |
| Sep 30, 2022 | 24.21 Mn |
| Jun 30, 2022 | 24.31 Mn |
| Mar 31, 2022 | 24.41 Mn |
| Dec 31, 2021 | 24.50 Mn |
| Sep 30, 2021 | 24.59 Mn |
| Jun 30, 2021 | 24.67 Mn |